The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $499,238 in first-year total cost, median $169,488.
Most frequent study sections
- Special Emphasis Panel[ZRG1 CB-R (55)]2
- Special Emphasis Panel[ZRG1 CB-C (55)]1
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL1
- BRIGHAM AND WOMEN'S HOSPITAL1
- UNIVERSITY OF MINNESOTA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Transitional Growth-Associated Skeletal Stem Cells1R03AG054723-01 | CARLONE, DIANA LYNN | BOSTON CHILDREN'S HOSPITAL, MA | $177,000 | ZRG1 |
| 2017 | Rejuvenation of the Lung1R03AG054664-01 | PANOSKALTSIS-MORTARI, ANGELA | UNIVERSITY OF MINNESOTA, MN | $152,750 | ZRG1 |
| 2015 | Circulating FSTL3 and Age-related Cardiac Hypertrophy1R03AG049657-01 | LEE, RICHARD T | BRIGHAM AND WOMEN'S HOSPITAL, MA | $169,488 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.